Recently, deep learning with neural networks has been applied in virtual drug screening.

Several research groups have demonstrated that data from multiple diseases can be leveraged with multitask neural networks to improve the virtual screening effectiveness. This is the first time the effect of adding additional data has been quantified in this domain, and our results suggest that even more data could improve performance even further.

Google Research and Stanford Pande Lab 3/2/15